Literature DB >> 1253392

Heparin kinetics in venous thrombosis and pulmonary embolism.

J Hirsh, W G van Aken, A S Gallus, C T Dollery, J F Cade, W L Yung.   

Abstract

The response to a standard dose of heparin was studied in 20 patients with venous thromboembolism. The heparin regimen consisted of intravenous injection of 70 units per kg, followed after 90 minutes by a maintenance dose of 400 units per kg per 24 hours given by continuous infusion. Plasma heparin activity and the activated partial thromboplastin time (APTT) were measured at intervals to determine clearance of the initial injection and the response to maintenance dose. Large inter-individual variations were found in the anticoagulant effect and these were due in part to differences in heparin clearance and in part to differences in the APTT response to given amounts of heparin (heparin effect index). The heparin half-life was 63 +/- 15 minutes when plasma heparin activities were used for this calculation and 84 +/- 71.5 minutes when the APTT was used. These results are similar to values previously reported in normal volunteers. Four of the 20 patients had pulmonary embolism and in these heparin half-life was significantly shortened (P less than 0.005).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1253392     DOI: 10.1161/01.cir.53.4.691

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  42 in total

Review 1.  The pulmonary physician and critical care. 5. Management of pulmonary embolism.

Authors:  H H Gray; S Firoozan
Journal:  Thorax       Date:  1992-10       Impact factor: 9.139

2.  Issues Regarding the Use of Heparin Following Streptokinase Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

Review 3.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  The principles and practice of anticoagulant therapy.

Authors:  C J Carter
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

Review 5.  Pulmonary embolism in parenteral nutrition.

Authors:  C M Dollery
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

6.  Guidelines to control heparin treatment.

Authors:  A G Fennerty; S Renowden; N Scolding; D P Bentley; I A Campbell; P A Routledge
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-01

7.  LOW MOLECULAR WEIGHT HEPARINS.

Authors:  S K Sharma
Journal:  Med J Armed Forces India       Date:  2017-06-26

8.  Intravenous heparin dosing strategy in hospitalized patients with atrial dysrhythmias.

Authors:  Robert O Roswell; Brian Greet; Sunny Shah; Samuel Bernard; Alexandra Milin; Iryna Lobach; Yu Guo; Martha J Radford; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 9.  Anticoagulation therapy in children.

Authors:  Milind D Ronghe; Christina Halsey; Nicholas J Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 10.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.